Diagnostics Pipeline: Savara Introduces Blood Test to Detect aPAP, a Rare Lung Disorder
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Emerging Tests-dtet
Image-Based AI Touted as a New Weapon Against Rare Cancers
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
Diagnostics Pipeline: Roche’s New Cobas Liat Panel Can Test for Multiple STIs Simultaneously
The PCR-driven test provides results in about 20 minutes in non-laboratory settings
Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections
From - Diagnostic Testing & Emerging Technologies
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by…
Researchers Find Marker That May Aid Diagnosis of Erectile Dysfunction
From - Diagnostic Testing & Emerging Technologies
The neutrophil-lymphocyte ratio (NLR) may be a marker to aid in diagnosing erectile dysfunction (ED), according to…
HPV DNA from Oral Rinse Samples May Be Prognostic Marker for Head, Neck Cancer
From - Diagnostic Testing & Emerging Technologies
Samples collected from a mouth rinse can detect human papillomavirus (HPV) DNA. These easily collected samples might provide important monitoring information for…
Improved Accuracy of Point-of-Care HbA1c Tests May Expand Access to Testing
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration-cleared POC Afinion HbA1c Dx test (Alere Technologies a subsidiary of Abbott Laboratories) is accurate and…
Already a member? Log in here
New Point-of Care Paper Test May Improve Diagnosis of Preeclampsia
From - Diagnostic Testing & Emerging Technologies
The Congo Red Dot (CRD) Paper Test is a simple, rapid, non-invasive tool that that may improve triage and the accuracy of preeclampsia (PE) diagnosis at the point of care, according to…
Progress Seen With EGFR Testing, But Adoption Still Lagging
From - Diagnostic Testing & Emerging Technologies
Incomplete implementation of EGFR testing guidelines remains a problem in the realm of non-small cell lung cancer (NSCLC), according to a study published in…
Can a Blood Test Quantify Pain?
From - Diagnostic Testing & Emerging Technologies
A new test could help clinicians objectively measure pain. According to a study published…
Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies
From - Diagnostic Testing & Emerging Technologies
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last…
Donor-Derived, Cell-Free DNA May Predict Lung Transplant Rejection
From - Diagnostic Testing & Emerging Technologies
Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and…